Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 337

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Interleukin‐23: as a drug target for autoimmune inflammatory diseases

Open access
Tang, Chunlei, Chen, Shu, Qian, Hai, Huang, Wenlong·2012·Immunology

Abstract

Summary: Interleukin‐23 (IL‐23) is a member of the IL‐12 family of cytokines with pro‐inflammatory properties. Its ability to potently enhance the expansion of T helper type 17 (Th17) cells indicates the responsibility for many of the inflammatory autoimmune responses. Emerging data demonstrate that IL‐23 is a key participant in central regulation of the cellular mechanisms involved in inflammation. Both IL‐23 and IL‐17 form a new axis through Th17 cells, which has evolved in response to human diseases associated with immunoactivation and immunopathogeny, including bacterial or viral infections and chronic inflammation. Targeting of IL‐23 or the IL‐23 receptor or IL‐23 axis is a potential therapeutic approach for autoimmune diseases including psoriasis, inflammatory bowel disease, rheumatoid arthritis and multiple sclerosis. The current review focuses on the immunobiology of IL‐23 and summarizes the most recent findings on the role of IL‐23 in the pre‐clinical and ongoing clinical studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2567.2011.03522.x

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 105 references

Cited by

See all 337

Metadata

Authors
Tang, C., Chen, S., Qian, H., & Huang, W.
Venue
Immunology
Publisher
Wiley
Published
2012-01-11
Volume
135
Issue
2
Pages
112-124
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W1607828984
Cited by
337
References
105
FWCI
5.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin‐23: as a drug target for autoimmune inflammatory diseases. https://app.cochat.ai/papers/10.1111/j.1365-2567.2011.03522.x
The paper
Tang, C., Chen, S., Qian, H., & Huang, W. (2012). Interleukin‐23: as a drug target for autoimmune inflammatory diseases. Immunology. https://doi.org/10.1111/j.1365-2567.2011.03522.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.